These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8524384)

  • 1. HIV. An elusive soluble suppressor.
    Fauci AS
    Nature; 1995 Dec; 378(6557):561. PubMed ID: 8524384
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV suppression by interleukin-16.
    Baier M; Werner A; Bannert N; Metzner K; Kurth R
    Nature; 1995 Dec; 378(6557):563. PubMed ID: 8524386
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of IL-16 in HIV replication.
    Mackewicz CE; Levy JA; Cruikshank WW; Kornfeld H; Center DM
    Nature; 1996 Oct; 383(6600):488-9. PubMed ID: 8849720
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
    Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into HIV-specific immune function: implications for therapy and prevention in the new millennium.
    Moss RB; Jensen FC; Carlo DJ
    Clin Immunol; 2000 May; 95(2):79-84. PubMed ID: 10779400
    [No Abstract]   [Full Text] [Related]  

  • 6. Elusive HIV-suppressor factors found.
    Balter M
    Science; 1995 Dec; 270(5242):1560-1. PubMed ID: 7502059
    [No Abstract]   [Full Text] [Related]  

  • 7. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.
    Zhang L; Yu W; He T; Yu J; Caffrey RE; Dalmasso EA; Fu S; Pham T; Mei J; Ho JJ; Zhang W; Lopez P; Ho DD
    Science; 2002 Nov; 298(5595):995-1000. PubMed ID: 12351674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simian immunodeficiency viruses with defective nef genes show increased susceptibility to the noncytotoxic antiviral activity of CD8+ lymphocytes.
    Binninger-Schinzel D; Norley S; Adler HS; Oberg HH; Kurth R
    Virology; 2002 Mar; 294(1):209-21. PubMed ID: 11886279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A screening assay for detecting CD8+ cell non-cytotoxic anti-HIV responses.
    Killian MS; Ng S; Mackewicz CE; Levy JA
    J Immunol Methods; 2005 Sep; 304(1-2):137-50. PubMed ID: 16129447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4(+) and CD8(+) T cell death during human immunodeficiency virus infection in vitro.
    Blanco J; Barretina J; Cabrera C; Gutiérrez A; Clotet B; Esté JA
    Virology; 2001 Jul; 285(2):356-65. PubMed ID: 11437669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells.
    Smithgall MD; Wong JG; Critchett KE; Haffar OK
    J Immunol; 1996 Mar; 156(6):2324-30. PubMed ID: 8690924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
    Bonneau KR; Ng S; Foster H; Choi KB; Berkhout B; Rabson A; Mackewicz CE; Levy JA
    Virology; 2008 Mar; 373(1):30-8. PubMed ID: 18086484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 lymphocytes in HIV infection: helpful and harmful.
    Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
    J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cell depletion amplifies hepatitis C virus replication in peripheral blood mononuclear cells.
    Li Y; Wang X; Douglas SD; Metzger DS; Woody G; Zhang T; Song L; Ho WZ
    J Infect Dis; 2005 Sep; 192(6):1093-101. PubMed ID: 16107965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women.
    Wang Y; Tao L; Mitchell E; Bravery C; Berlingieri P; Armstrong P; Vaughan R; Underwood J; Lehner T
    Nat Med; 1999 Sep; 5(9):1004-9. PubMed ID: 10470076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic killing of CD4+ T lymphocytes in HIV-1-infected PHA-stimulated PBL cultures is mediated by CD8+ LAK cells.
    Wang L; Klimpel GR; Planas JM; Li H; Cloyd MW
    Virology; 1998 Feb; 241(2):169-80. PubMed ID: 9499792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-9 receptor alpha chain mRNA formation in CD8+ T cells producing anti-human immunodeficiency virus type 1 substance(s).
    Hossain MM; Tsuchie H; Detorio MA; Shirono H; Hara C; Nishimoto A; Saji A; Koga J; Takata N; Maniar JK; Saple DG; Taniguchi K; Kageyama S; Ichimura H; Kurimura T
    Acta Virol; 1998 Feb; 42(1):47-53. PubMed ID: 9645243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption.
    Martini F; Poccia F; Goletti D; Carrara S; Vincenti D; D'Offizi G; Agrati C; Ippolito G; Colizzi V; Pucillo LP; Montesano C
    J Infect Dis; 2002 Sep; 186(6):847-50. PubMed ID: 12198622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.